Journals / Turkish Journal of Pharmaceutical Sciences / 2020 / Cilt: 17 - Sayı: 4

Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach

Faktöriyel Yaklaşım ile Nikorandil İçeren Biyoadezif Bukkal Tabletlerin Geliştirilmesi

Pages
388–397
Publication Date
2022-11-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The zero-order release kineticsmodel best fitted the optimized batch release profile, suggesting the system would release the drug at a constant rate.Conclusion: The release by the optimized formulation of the drug at a sustained rate along with its bioadhesive nature showed that the buccal routecan be an option for the administration of nicorandil.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In the present investigation, bioadhesive buccal tablets were prepared using the sustained-release polymer hydroxypropyl methylcellulose(HPMC) K100M, bioadhesive polymer neem gum, and an impervious backing layer of ethyl cellulose.
📊
Key Findings & Data:Nicorandil is sensitive to the first-pass effect;therefore, a buccal-adhesive dosage form can avoid this effect.Materials and Methods: We used the direct compression technique to prepare the tablet formulation.
💡
Conclusion & Impact:The zero-order release kineticsmodel best fitted the optimized batch release profile, suggesting the system would release the drug at a constant rate.Conclusion: The release by the optimized formulation of the drug at a sustained rate along with its bioadhesive nature showed that the buccal routecan be an option for the administration of nicorandil.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: In the present investigation, bioadhesive buccal tablets were prepared using the sustained-release polymer hydroxypropyl methylcellulose(HPMC) K100M, bioadhesive polymer neem gum, and an impervious backing layer of ethyl cellulose. Nicorandil is sensitive to the first-pass effect;therefore, a buccal-adhesive dosage form can avoid this effect.Materials and Methods: We used the direct compression technique to prepare the tablet formulation. A 32 full factorial design was composed inwhich the amounts of HPMC K100M (X1) and neem gum (X2) were chosen as the independent variables and the dependent variables were thepercentage drug release at 6 h (Y1) and mucoadhesive strength in grams (Y2). Various in vitro parameters, i.e. thickness, friability, hardness, weightvariation, surface pH, moisture absorption ratio, dissolution studies, and drug release kinetics, and ex vivo parameters like mucoadhesive strengthand mucoadhesion time were determined for the prepared tablets. We subjected the optimized batch to a comparison with the marketed formulationand stability studies were performed.Results: The formulation containing a 50:50 ratio of neem gum and HPMC K100M (F5) was considered optimum. The zero-order release kineticsmodel best fitted the optimized batch release profile, suggesting the system would release the drug at a constant rate.Conclusion: The release by the optimized formulation of the drug at a sustained rate along with its bioadhesive nature showed that the buccal routecan be an option for the administration of nicorandil.

Özet

Amaç: Bu araştırmada, biyoadesif bukkal tabletler sürekli salımlı polimer hidroksipropil metilselüloz (HPMC) K100M, biyoadesif polimer neem sakızı ve geçirimsiz etil selüloz arka tabaka kullanılarak hazırlanmıştır. Nikorandil ilk geçiş etkisine karşı duyarlıdır. Bu nedenle, bukal adesif dozaj formu bu etkiyi önleyebilir. Gereç ve Yöntemler: Tablet formülasyonu hazırlamak için doğrudan sıkıştırma tekniği kullanılmıştır. HPMCK 100M (X1) ve neem sakızı (X2) miktarları bağımsız değişken olarak ve 6. saat (Y1) ilaç salımı yüzdesi ve gram biriminde mukoadhersif güç yüzde bağımlı değişkenler olarak seçilerek 32tam faktöriyel tasarımı oluşturulmuştur. Hazırlanan tabletler için farklı in vitro parametreler (kalınlık, ufalanma, sertlik, ağırlık sapması, yüzeysel pH’sı, nem absorpsiyon oranı, çözünme çalışmaları ve ilaç salım kinetikleri) ve ex vivo parametreler (mukoadesif güç ve mukoadesif zaman) belirlenmiştir. Optimize etilen seri piyasadaki formülasyon ile karşılaştırılmış ve stabilite çalışmaları yapılmıştır. Bulgular: 50:50 oranında neem zamkı ve HPMC K100M içeren formülasyon (F5)’in en uygun olduğu kabul edilmiştir. Sıfır derece salım kinetiği modeli optimize seri salım profiline en iyi düzeyde uymuştur ve bu sistemin ilacı sabit bir hızda salım sağlayacağını belirtmektedir. Sonuç: İlacın optimize edilmiş formülasyonunun biyoadesif özelliğinin yanında sürdürülebilir hızla salımı nikorandilin bukkal yol ile uygulanmasının bir seçenek olacağını göstermiştir

🔖

Cite This Article

KOTADIYA, R., SHAH, K. (2022). Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach. Turkish Journal of Pharmaceutical Sciences, Cilt: 17 - Sayı: 4, 388–397. https://ajindex.com/articles/613752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ahmed AB, Nath LK. Design and development of controlled release floating matrix tablet of Nicorandil using hydrophilic cellulose and pHindependent acrylic polymer: in-vitro and in-vivo evaluations. Expert Opin Drug Deliv. 2016;13:315-324
  2. Falase B, Easaw J, Youhana A. The role of nicorandil in the treatment of myocardial ischaemia. Expert Opin Pharmacother. 2001;2:845-856
  3. Singh B, Garg T, Goyal AK, Rath G. Development, optimization, and characterization of polymeric electrospun nanofiber: a new attempt in sublingual delivery of nicorandil for the management of angina pectoris. Artif Cells Nanomed Biotechnol. 2016;44:1498-1507
  4. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. Controlled in vivo release of nicorandil from a carvone-based transdermal therapeutic system in human volunteers. Drug Deliv. 2006;13:69-77
  5. Prajapati G, Patel R. Design and in vitro evaluation of novel nicorandil sustained release matrix tablets based on combination of hydrophillic and hydrophobic matrix systems. International Journal of Pharmaceutical Sciences Review and Research. 2010;1:33-38
  6. Tamilvanan S, Babu VR, Nappinai A, Sivaramakrishnan G. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymersbased nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet. Drug Development and Industrial Pharmacy. 2011;37:436-445
  7. Boddupalli BM, Mohammed ZN, Nath RA, Banji D. Mucoadhesive drug delivery system: An overview. J Adv Pharm Technol Res. 2010;1:381-387
  8. Chinna Reddy P, Chaitanya KS, Madhusudan Rao Y. A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. Daru. 2011;19:385-403
  9. Hoogstraate JAJ, Wertz PW, Wertz PW. Drug delivery via the buccal mucosa. Pharmaceutical Science Technology Today. 1998;1:309-316
  10. Mohamed FAA, Roberts M, Seton L, Ford JL, Levina M, Rajabi-Siahboomi AR. Production of extended release mini-tablets using directly compressible grades of HPMC. Drug Dev Ind Pharm. 2013;39:1690-1697
  11. Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev Ind Pharm. 2004;30:995-1004
  12. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci. 1999;2:53-61
  13. Wong CF, Yuen KH, Peh KK. Formulation and evaluati